The AcceleDent® device has been introduced to the specialty of orthodontics in order to
reduce treatment time. The theory behind AcceleDent® is that high frequency vibratory forces
(30Hz) delivered to the teeth will stimulate the bone remodeling that is necessary for tooth
movement to occur more quickly.
Additionally, one claim of the AcceleDent® product is that it may reduce pain and discomfort
during orthodontic treatment.
This study will be a parallel group, triple-blind randomized clinical trial comparing two
groups of subjects with 12 participants in each group. Subjects will be randomized to receive
one of two vibrational units, which will differ in frequency and/or amplitude of vibration.
The subjects will be asked to change their aligners every week instead of every 2 weeks,
which is common with Invisalign.
1. Patients with malocclusions that require minor or no anterior-posterior or transverse
correction in the posterior teeth, and are planned for <= 25 aligners to complete
2. Treatment must be dual arch in order for patients to qualify for this study.
3. Patients must be 18 years or older
1. Patients with systematic diseases or syndromes
2. Patients with a history or current use of Bisphosphonates
3. Patients with current use of nonsteroidal anti-inflammatory drugs
4. Patients with generalized moderate to severe periodontitis
5. Patients with active oral hard tissue or soft tissue lesions
6. Patients with chronic oral and maxillofacial conditions such as trigeminal neuralgia,
TMD and orofacial pain.